Pfizer’s COVID-19 Vaccine Less Protective Against Hospitalization After Omicron Emerged: Study

Pfizer’s COVID-19 Vaccine Less Protective Against Hospitalization After Omicron Emerged: Study
Vials of the Pfizer-BioNTech COVID-19 vaccine are seein in Cape Town, South Africa on Dec. 8, 2021. Rodger Bosch/AFP via Getty Images
Zachary Stieber
Updated:

The Pfizer-BioNTech COVID-19 vaccine has been less effective in protecting against hospitalization following the emergency of the Omicron virus variant, according to a new study of real-world data from South Africa.

The protection from the vaccine’s primary two-dose regimen has dropped to about 70 percent in recent weeks, according to Discovery Health, the largest private health insurance company in the country.
Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics